Correspondence 0001193125-24-261816 from Instil Bio, Inc. (TIL) (CIK 0001789769) (TIL)
Instil Bio, Inc. (TIL) (CIK 0001789769)
Date: Nov. 19, 2024 · CIK: 0001789769 · Accession: 0001193125-24-261816
AI Filing Summary & Sentiment
File numbers found in text: 333-283205
Show Raw Text
CORRESP 1 filename1.htm CORRESP INSTIL BIO, INC. 3963 Maple Avenue, Suite 350 Dallas, Texas 75219 (972) 499-3350 November 19, 2024 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Instil Bio, Inc. Registration Statement on Form S-3 Filed November13, 2024 File No. 333- 283205 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-283205) (the “Registration Statement”) to become effective on Thursday, November 21, 2024, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Courtney Tygesson of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Courtney Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680, or in her absence David Brinton of Cooley LLP at (202) 776-2989. Very truly yours, INSTIL BIO, INC. By: /s/ Bronson Crouch Name: Bronson Crouch Title: Chief Executive Officer cc: Courtney Tygesson, Cooley LLP